Nutex Health enters $100M pre-paid advance with Yorkville; initial $15M at 90% of face

Nutex Health Inc.

Aggregate commitment $100M over 18 months; initial $15M funded, second $10M contingent on VWAP >= $0.60.
Purchase price 90% of face; conversion price floor $0.1851; shares issued at lower of VWAP or 92% of two lowest daily VWAPs.
Yorkville capped at 4.99% beneficial ownership; aggregate issuances limited to 19.9% of shares (Nasdaq Cap); no short sales.
Lincoln Park Capital waives its equity line while PPA outstanding >$1M; Nutex agrees not to terminate LPCF for 24 months.
Proceeds to support growth, acquisitions, potential stock buybacks, and working capital.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Nutex Health Inc. entered into Pre-Paid Advance Agreement (PPA) with YA II PN, Ltd. valued at Up to $25,000,000 initial Pre-Paid Advance, aggregate limit $100,000,000 (effective 2023-04-11).

Action: entry
Agreement: equity purchase
Counterparty: YA II PN, Ltd.
Value: Up to $25,000,000 initial Pre-Paid Advance, aggregate limit $100,000,000
Effective: 2023-04-11

Exact text from the filing

On April 11, 2023, Nutex Health Inc. (the “Company”) entered into a Pre-Paid Advance Agreement (the “PPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Investor”).

View on SEC.gov

Browse all material agreements →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-044380

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.